STATEMENT – Innovative Health Seeks Permanent Injunction Against Johnson & Johnson Medtech’s Biosense Webster Following Landmark Antitrust Win
Motion filed includes evidence and testimony presented at trial demonstrating the lengths Johnson & Johnson MedTech’s Biosense Webster went to “crush” reprocessor competitors June 20, 2025 FOR IMMEDIATE RELEASE [Note to Editors: The case information discussed in this statement is publicly accessible on PACER and is summarized from the following documents, which AMDR has highlighted
Triple Damages — $442M — Awarded to AMDR Member Innovative Health in Case Against Johnson & Johnson’s Biosense Webster Medical Technology Unit for Withholding Technical Support When Reprocessed Devices Were Used
[Washington, D.C. and Berlin, Germany / 5 June 2025] Today, Judge James V. Selna of the U.S. District Court for the Central District of California entered judgment in Innovative Health LLC v. Biosense Webster, Inc., tripling the jury’s May 16 award from $147 million to $442 million under federal and California antitrust statutes. The judgment
STATEMENT On $147M Verdict for AMDR Member Innovative Health Against Johnson & Johnson’s Biosense Webster Medical Technology Unit
[Washington, D.C. and Berlin, Germany / 18 May 2025] Friday’s unanimous verdict by a federal jury in Santa Ana, California for Innovative Health against Johnson & Johnson (NYSE: JNJ) is a victory for America’s hospitals, providers, patients, and the environment. The jury found that Biosense Webster violated federal and state antitrust laws by withholding clinical
Earth Day News: Hospitals and Surgical Centers in 17 Countries Partnered with AMDR Members to Save over $451M (€433M), Eliminate the Equivalent of over 115M Pounds (52M kg) of CO₂ Emissions, by Using Regulated, Reprocessed “Single-Use” Medical Devices in 2024
[Washington, DC / Berlin Germany – 22 April 2025] In commemoration of Earth Day, the Association of Medical Device Reprocessors and its members released the results of its 2024 member survey. Among the key findings (all data for 2024): Members helped health systems save $451,183,153 through cost savings (reprocessed “single-use” medical devices (SUDs) cost 30
Position Paper: The Time Has Come To Change the “Opt-In” Provision of the EU MDR (Article 17)
The “Opt-In” Provision of the EU MDR (Article 17): Undermines EU Law and the Single Market Deprives Hospitals of Sustainable Medical Device Options, and Exacerbates Shortages in the Healthcare Supply Chain The time has come to change it. Summary Health systems are under enormous pressure. Urgently needed amendments to Article 17 of the EU Medical
New AMDR Member Survey Finds Hospitals and Surgical Centers Saved over $465MM (€426MM), Avoided over 98MM Pounds (44.5MM Kg) of Greenhouse Gas Emissions by Using Regulated, Reprocessed Single-Use Medical Devices from AMDR Members in 2023
[Washington, DC / Berlin Germany – 16 October 2024] A record 11,967 hospitals and surgical centers saved nearly half a billion dollars and eliminated greenhouse gas emissions equivalent to 7.5 Olympic swimming pools filled with gasoline by opting for regulated, commercially reprocessed 'single-use' medical devices (SUDs) instead of virgin SUDs in 2023. The data comes
AMDR Statement: Separating the Facts from the Myths about FDA Regulated, Reprocessed LigaSures™
23 September 2024 Statement from AMDR: Separating the Facts from the Myths about FDA Regulated, Reprocessed LigaSures™ In September 2020, a Medtronic-funded study purporting to show soiled reprocessed LigaSure devices was published in the Journal Surgical Endoscopy. After an exhaustive, year-long independent review by the publisher, an important correction was added to the article, indicating
AMDR Action Alert: Your Voice Matters – Hospital Purchasing Representatives Encouraged to Report Anticompetitive SUD Purchasing Contracts and Related Behavior
Last December, the Biden Administration declared war on corporate greed in healthcare. The announcement included a range of fronts in the war, from fighting bloated drug costs to attacking anticompetitive contracts that cause unnecessary waste for hospitals, payors, and the patients they serve. As reported by Healthcare Business News, the White House announcement led the